1. 1. TB India 2011. Annual status report. Central TB division. Director General of Health Services, Ministry of Health and Family Welfare, Government of India.
2. 2. RNTCP launches category IV treatment (DOTS PLUS treatment) for MDR patients of Gujarat on 29th august 2007.(available from www.tbcindia.org)
3. 3. WHO/ IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World. Report No.4. Geneva, Switzerland: WHO; WHO/HTM/TB/2008.394.
4. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control;SK;Chest,2006
5. 5. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001; 5: 887-93.